CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 41 filers reported holding CLEVELAND BIOLABS INC in Q4 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $27,000 | 0.0% | 114,307 | 0.0% | 0.00% | – |
| Q4 2014 | $27,000 | -48.1% | 114,307 | 0.0% | 0.00% | – |
| Q3 2014 | $52,000 | -5.5% | 114,307 | 0.0% | 0.00% | – |
| Q2 2014 | $55,000 | -31.2% | 114,307 | 0.0% | 0.00% | – |
| Q1 2014 | $80,000 | -38.0% | 114,307 | 0.0% | 0.00% | – |
| Q4 2013 | $129,000 | -27.5% | 114,307 | 0.0% | 0.00% | – |
| Q3 2013 | $178,000 | -1.7% | 114,307 | 0.0% | 0.00% | – |
| Q2 2013 | $181,000 | – | 114,307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 640,700 | $750,000 | 0.14% |
| GOODNOW INVESTMENT GROUP, LLC | 560,461 | $656,000 | 0.11% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 752,038 | $999,000 | 0.03% |
| Winfield Associates, Inc. | 15,711 | $18,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 157,249 | $184,000 | 0.01% |
| Van Cleef Asset Management,Inc | 20,000 | $23,000 | 0.01% |
| ACG Wealth | 31,600 | $37,000 | 0.01% |
| KINGS POINT CAPITAL MANAGEMENT | 10,000 | $12,000 | 0.00% |
| TAURUS ASSET MANAGEMENT, LLC | 15,000 | $18,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 115,249 | $135,000 | 0.00% |